Global Small Interfering RNA (siRNA) Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Small Interfering RNA (siRNA) Market Insights, Forecast to 2034
Small interfering RNA (siRNA) is a kind of endogenous single stranded RNA with regulatory function found in Eukaryote, generally 18-25nt. It can cause the degradation of target mRNA and inhibit its translation through specific binding with target mRNA, so as to regulate the post transcriptional expression of genes. Recent studies have shown that miRNAs are involved in various regulatory pathways, including development, viral defense, hematopoietic processes, organ formation, cell proliferation and apoptosis, and fat metabolism. DIA-UP's advanced chemical synthesis technology can provide customers with products such as miRNA inhibitors, miRNA mimetics, miRNA negative controls, Agomir, and Antagonir.
Market Analysis and InsightsGlobal Small Interfering RNA (siRNA) Market
Global Small Interfering RNA (siRNA) market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Small Interfering RNA (siRNA) industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Small Interfering RNA (siRNA) key companies include Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc., New England Biolabs and Quantabio, etc. Agilent Technologies, Merck KGaA, QIAGEN (Exiqon) are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Small Interfering RNA (siRNA) were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Small Interfering RNA (siRNA) market and estimated to attract more attentions from industry insiders and investors.
Small Interfering RNA (siRNA) can be divided into General Chemical Synthesis of siRNA and Sterol Modified Chemical Synthesis of siRNA, etc. General Chemical Synthesis of siRNA is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Small Interfering RNA (siRNA) is widely used in various fields, such as Cancer, Infectious Diseases, Immunological Disorder and Cardiovascular Disease, etc. Cancer provides greatest supports to the Small Interfering RNA (siRNA) industry development. In 2022, global % revenue of Small Interfering RNA (siRNA) went into Cancer filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Small Interfering RNA (siRNA) market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Small Interfering RNA (siRNA) market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
Agilent Technologies
Merck KGaA
QIAGEN (Exiqon)
NanoString Technologies, Inc.
Dharmacon (Horizon Discovery Group)
Synlogic
GeneCopoeia, Inc.
New England Biolabs
Quantabio
NanoString Technologies, Inc.
BioGenex
SeqMatic LLC
Segment by Type
General Chemical Synthesis of siRNA
Sterol Modified Chemical Synthesis of siRNA
Cancer
Infectious Diseases
Immunological Disorder
Cardiovascular Disease
Neurological Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Small Interfering RNA (siRNA) introduction, etc. Small Interfering RNA (siRNA) Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Small Interfering RNA (siRNA)
Chapter 13Methodology and Data Sources adopted by MRAResearch
Market Analysis and InsightsGlobal Small Interfering RNA (siRNA) Market
Global Small Interfering RNA (siRNA) market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Small Interfering RNA (siRNA) industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, Small Interfering RNA (siRNA) key companies include Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc., New England Biolabs and Quantabio, etc. Agilent Technologies, Merck KGaA, QIAGEN (Exiqon) are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Small Interfering RNA (siRNA) were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Small Interfering RNA (siRNA) market and estimated to attract more attentions from industry insiders and investors.
Small Interfering RNA (siRNA) can be divided into General Chemical Synthesis of siRNA and Sterol Modified Chemical Synthesis of siRNA, etc. General Chemical Synthesis of siRNA is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Small Interfering RNA (siRNA) is widely used in various fields, such as Cancer, Infectious Diseases, Immunological Disorder and Cardiovascular Disease, etc. Cancer provides greatest supports to the Small Interfering RNA (siRNA) industry development. In 2022, global % revenue of Small Interfering RNA (siRNA) went into Cancer filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Small Interfering RNA (siRNA) market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Small Interfering RNA (siRNA) market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report
By Company
Agilent Technologies
Merck KGaA
QIAGEN (Exiqon)
NanoString Technologies, Inc.
Dharmacon (Horizon Discovery Group)
Synlogic
GeneCopoeia, Inc.
New England Biolabs
Quantabio
NanoString Technologies, Inc.
BioGenex
SeqMatic LLC
Segment by Type
General Chemical Synthesis of siRNA
Sterol Modified Chemical Synthesis of siRNA
Segment by Application
Cancer
Infectious Diseases
Immunological Disorder
Cardiovascular Disease
Neurological Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Small Interfering RNA (siRNA) introduction, etc. Small Interfering RNA (siRNA) Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Small Interfering RNA (siRNA)
Chapter 13Methodology and Data Sources adopted by MRAResearch
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices